马方综合征患者脊柱侧凸术后阿片类药物使用量高于青少年特发性脊柱侧凸患者
回顾性匹配队列研究比较马方综合征(MFS)与青少年特发性脊柱侧凸(AIS)患者后路脊柱融合术(PSF)后阿片类药物使用情况。MFS患者住院期间总吗啡毫克当量(MME)用量、静脉患者自控镇痛时长及出院后阿片处方请求均显著高于AIS患者。
要点
- MFS患者住院总MME用量为4.9 vs AIS患者2.1 mg/kg(P≤0.001)。
- MFS患者出院后请求阿片处方的比值比为4.1(95%CI 1.1-14.9,P=0.03)。
- MFS患者出院阿片处方剂量更高(1.0 vs 0.72 MME/天/kg,P≤0.001)且疗程更长(13 vs 8天,P=0.005)。
核心结论
- 尽管干预相似,MFS与AIS患者PSF术后阿片类药物使用似乎存在差异,为未来研究提供了机会,以帮助临床医生更好地预判个体患者的镇痛需求,尤其考虑到当前阿片类药物流行问题。
研究设计与样本
- 回顾性匹配病例队列研究,将20例接受PSF的MFS青少年患者按年龄、性别、脊柱畸形程度和融合椎体节数1:2匹配AIS患者,审查住院和门诊药品数据中阿片类及辅助药物的数量与持续时间,并使用CDC标准换算因子转换为MME。
主要发现
- MFS患者住院总MME用量显著高于AIS患者(4.9 vs 2.1 mg/kg,P≤0.001)。
- MFS患者静脉患者自控镇痛持续时间长于AIS患者(3.4 vs 2.5天,P=0.001)。
- 术后前2天,尽管疼痛评分相似且辅助药物使用更多,MFS患者患者自控镇痛推注次数多于AIS患者(91 vs 52次,P=0.01)。
- 校正既往阿片使用后,MFS是出院后请求阿片处方的唯一显著预测因素(比值比4.1,95%CI 1.1-14.9,P=0.03)。
- MFS患者出院时更可能获得更强效的处方(1.0 vs 0.72 MME/天/kg,P≤0.001)和更长疗程的处方(13 vs 8天,P=0.005),门诊MME/kg更高(11.6 vs 5.6 mg/kg,P≤0.001)。
局限性
- 原文结论指出需要进一步研究以帮助临床医生更好地预判个体患者的镇痛需求。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY DESIGN: Retrospective matched case cohort. OBJECTIVE: Compare postoperative opioid utilization and prescribing behaviors between patients with Marfan syndrome (MFS) and adolescent idiopathic scoliosis (AIS) after posterior spinal fusion (PSF). SUMMARY OF BACKGROUND DATA: Opioids are an essential component of pain management after PSF. However, due to the potential for opioid use disorder and dependence, current analgesic strategies aim to minimize their use, especially in younger patients. Limited information exists on opioid utilization after PSF for syndromic scoliosis. PATIENTS AND METHODS: Twenty adolescents undergoing PSF with MFS were matched with patients with AIS (ratio, 1:2) by age, sex, degree of spinal deformity, and the number of vertebral levels fused. Inpatient and outpatient pharmaceutical data were reviewed for the quantity and duration of opioid and adjunct medications. Prescriptions were converted to morphine milligram equivalents (MMEs) using CDC's standard conversion factor. RESULTS: Compared with patients with AIS, patients with MFS had significantly greater total inpatient MME use (4.9 vs . 2.1 mg/kg, P ≤ 0.001) and longer duration of intravenous patient-controlled anesthesia (3.4 vs . 2.5 d, P = 0.001). Within the first 2 postop days, MFS patients had more patient-controlled anesthesia boluses (91 vs . 52 boluses, P = 0.01) despite similar pain scores and greater use of adjunct medications. After accounting for prior opioid use, MFS was the only significant predictor of requesting an opioid prescription after discharge (odds ratio: 4.1, 95% CI: 1.1-14.9, P = 0.03). Patients with MFS were also more likely to be discharged with a more potent prescription (1.0 vs . 0.72 MME per day/kg, P ≤ 0.001) and to receive a longer-duration prescription (13 vs . 8 d, P = 0.005) with a greater MME/kg (11.6 vs . 5.6 mg/kg, P ≤ 0.001) as outpatients. CONCLUSION: Despite a similar intervention, patients with MFS and AIS seem to differ in their postoperative opioid usage after PSF, presenting an opportunity for further research to assist clinicians in better anticipating the analgesic needs of individual patients, particularly in light of the ongoing opioid epidemic.
引用
- Benes GA, Hunsberger JB, Dietz HC, et al. Opioid Utilization After Scoliosis Surgery is Greater in Marfan Syndrome Than Adolescent Idiopathic Scoliosis. Spine (Phila Pa 1976). 2023. PMID: 37294802. doi:10.1097/BRS.0000000000004741
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。